Mission Produce's Valuation Looks Expensive: Buy Now or Wait?

Mission Produce trades at a premium 16.67x forward P/E versus the 15.04x industry average and 0.57x price-to-sales versus 0.56x, while shares are down 11.7% over the past year. Fiscal Q2 2026 revenue fell 24% to $290.9 million and adjusted EBITDA dropped to $7.1 million as an unusually large Mexican avocado crop pressured pricing, though demand remains strong and margins are improving as supply normalizes. EPS estimates were cut 23.9% for FY2026 and 19.7% for FY2027, but long-term growth is supported by record U.S. avocado consumption and Calavo-related synergies.

Analysis

AVO is in the classic middle ground where the long-duration story is intact but the next 2-3 quarters are likely to be dominated by inventory/price normalization rather than demand acceleration. The key second-order issue is that pricing power in a commodity-like agribusiness can unwind faster than volume can grow, so even modestly better consumer throughput does not translate cleanly into earnings until the supply mix rebalances. That makes the current multiple vulnerable if the market is still capitalizing cyclical margin recovery as though it were structural.

The bigger competitive implication is that the supply reset should eventually improve economics for whoever has the best sourcing flexibility and working-capital discipline, not necessarily the highest volume player. If AVO can arbitrage between Mexico, California, and Peru more efficiently than smaller operators, it can emerge with structurally better fill rates and lower spot exposure; if not, margin recovery will be capped and peers with cleaner balance sheets may rerate first. Calavo integration is the swing factor here because cost synergies are only valuable if they offset the hidden cost of more complex procurement and faster-moving inventory.

Consensus appears to be missing the timing mismatch: the market is paying for multi-year category growth while estimate revisions are still moving lower over the next two fiscal years. That usually creates a pocket where the stock looks optically cheap versus growth peers but remains expensive on trough earnings. The setup is less about whether avocados are a good category and more about whether AVO can convert category growth into durable per-unit economics before the valuation de-rates.

Key Decisions for Investors

• Avoid initiating fresh longs in AVO for now; wait for either a 1-2 quarter confirmation of margin normalization or a pullback toward the low end of its 52-week range. Risk/reward is poor while estimates are still being cut and the stock trades on forward earnings that likely remain fragile for the next 6 months.
• If already long AVO, consider a collar or covered-call structure over the next 3-4 months to monetize elevated valuation while limiting downside if pricing remains weak. Upside should be capped until the market sees evidence that mix/sourcing issues are resolved.
• Relative value: pair long ADM vs short AVO for 1-2 quarters. ADM has a cleaner earnings base and less dependence on near-term commodity price normalization; AVO has more estimate risk and higher multiple exposure.
• For more aggressive traders, use AVO call spreads only after a report that shows sequential gross margin improvement and stable pricing. The catalyst window is 1-2 earnings prints away, but the trade needs proof of execution, not just demand commentary.
• Watch for a post-integration synergy update on Calavo; if management can credibly accelerate annualized savings before the next fiscal year, AVO could re-rate. Until then, treat the stock as a hold with downside skew, not a buy-the-dip candidate.